Despina Fotiou

Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose

Evangelos Terpos, Ioannis P. Trougakos, Maria Gavriatopoulou et al. · Blood · 2021 · 148 citations · Full text

Medicine, Immunology, Oncology +16

The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment

Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos et al. · Blood Cancer Journal · 2021 · 128 citations · Full text

Veterinary Medicine, Immunology, Oncology +14

Cardiac and renal complications of carfilzomib in patients with multiple myeloma

Meletios Α. Dimopoulos, Maria Gavriatopoulou, Erasmia Psimenou et al. · Blood Advances · 2017 · 105 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Bortezomib‐based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis

Meletios Α. Dimopoulos, Maria Gavriatopoulou, Erasmia Psimenou et al. · American Journal of Hematology · 2016 · 93 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma

Efstathios Kastritis, Evangelos Terpos, Maria Gavriatopoulou et al. · Haematologica · 2016 · 89 citations · Full text

Medicine, Hematology, Oncology +15